{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:20:11Z","timestamp":1789017611795,"version":"build-2803163510"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1093\/jnci\/djt462","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T03:25:26Z","timestamp":1393557926000},"source":"Crossref","is-referenced-by-count":22,"title":["Risk for Developing Myelodysplastic Syndromes in Prostate Cancer Patients Definitively Treated With Radiation"],"prefix":"10.1093","volume":"106","author":[{"given":"Sudipto","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana A.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay P.","family":"Ciezki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon V.","family":"Tiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Copelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali A.","family":"Advani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogen","family":"Saunthararajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Paulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Bolwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Kalaycio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dreicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"issue":"(1)","key":"key\n\t\t\t\t20170520235528_CIT0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20170520235528_CIT0002","first-page":"139","article-title":"Second cancer following cancer of the male genital system in Connecticut, 1935\u201382","volume":"68","author":"Kleinerman","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"key\n\t\t\t\t20170520235528_CIT0003","first-page":"341","article-title":"Second cancer following cancer of the male genital system in Denmark, 1943\u201380","volume":"68","author":"Osterlind","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"issue":"2","key":"key\n\t\t\t\t20170520235528_CIT0004","first-page":"207","article-title":"Multiple cancer: an epidemiological exercise in Finland","volume":"75","author":"Teppo","year":"1985","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"key\n\t\t\t\t20170520235528_CIT0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00052939","article-title":"Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972\u201391","volume":"7","author":"McCredie","year":"1996","journal-title":"Cancer Causes Control"},{"issue":"2","key":"key\n\t\t\t\t20170520235528_CIT0006","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1097-0045(19971001)33:2<75::AID-PROS1>3.0.CO;2-L","article-title":"Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study","volume":"33","author":"Pawlish","year":"1997","journal-title":"Prostate"},{"issue":"3","key":"key\n\t\t\t\t20170520235528_CIT0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-8140(02)00307-9","article-title":"The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984\u20132000","volume":"65","author":"Pickles","year":"2002","journal-title":"Radiat Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170520235528_CIT0008","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.juro.2006.10.071","article-title":"Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavour","volume":"177","author":"Boorjian","year":"2007","journal-title":"J Urol"},{"issue":"8","key":"key\n\t\t\t\t20170520235528_CIT0009","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0","article-title":"Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma","volume":"79","author":"Neugut","year":"1997","journal-title":"Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170520235528_CIT0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.22083","article-title":"Cancer incidence after localized therapy for prostate cancer","volume":"107","author":"Moon","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"key\n\t\t\t\t20170520235528_CIT0011","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V","article-title":"Second malignancies in prostate cancer patients after radiotherapy compared with surgery","volume":"88","author":"Brenner","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"key\n\t\t\t\t20170520235528_CIT0012","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2004.12.038","article-title":"Increased risk of rectal cancer after prostate radiation: a population-based study","volume":"128","author":"Baxter","year":"2005","journal-title":"Gastroenterology"},{"issue":"(4)","key":"key\n\t\t\t\t20170520235528_CIT0013","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.urology.2009.02.085","article-title":"Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data","volume":"74","author":"Abdel-Wahab","year":"2009","journal-title":"Urology"},{"key":"key\n\t\t\t\t20170520235528_CIT0014","first-page":"257","volume-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20132000.","author":"McMaster","year":"2006"},{"issue":"(3)","key":"key\n\t\t\t\t20170520235528_CIT0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canep.2010.04.003","article-title":"Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma","volume":"34","author":"Ojha","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"key\n\t\t\t\t20170520235528_CIT0016","article-title":"SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Section 30.Bethesda, MD.","author":"Howlader"},{"issue":"(21)","key":"key\n\t\t\t\t20170520235528_CIT0017","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/jnci\/djn349","article-title":"Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys","volume":"100","author":"Sekeres","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"(5)","key":"key\n\t\t\t\t20170520235528_CIT0018","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2003.07.113","article-title":"Treatment-related myelodysplasia and acute leukemia in non-Hodgkin\u2019s lymphoma patients","volume":"21","author":"Armitage","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520235528_CIT0019","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1097-0142(19900701)66:1<80::AID-CNCR2820660116>3.0.CO;2-9","article-title":"Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas","volume":"66","author":"Lavey","year":"1990","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170520235528_CIT0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2407-11-260","article-title":"Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990\u20132005","volume":"11","author":"Kaplan","year":"2011","journal-title":"BMC Cancer"},{"issue":"24","key":"key\n\t\t\t\t20170520235528_CIT0021","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jnci\/djj497","article-title":"Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks","volume":"98","author":"Shuryak","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"key\n\t\t\t\t20170520235528_CIT0022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1088\/0031-9155\/26\/3\/003","article-title":"Active bone marrow distribution as a function of age in humans","volume":"26","author":"Cristy","year":"1981","journal-title":"Phys Med Biol"},{"issue":"1","key":"key\n\t\t\t\t20170520235528_CIT0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.04609.x","article-title":"Novel trafficking routes for hematopoietic stem and progenitor cells","volume":"1176","author":"Massberg","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"(4)","key":"key\n\t\t\t\t20170520235528_CIT0024","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"The proportion of second cancers attributable to radiotherapy treatment in adults: a prospective cohort study in the US SEER cancer registries","volume":"12","author":"de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170520235528_CIT0025","volume-title":"AJCC on Cancer Staging Manual.","author":"Fleming","year":"1997"},{"issue":"11","key":"key\n\t\t\t\t20170520235528_CIT0026","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"key\n\t\t\t\t20170520235528_CIT0027","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"(3)","key":"key\n\t\t\t\t20170520235528_CIT0028","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0360-3016(99)00454-X","article-title":"Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland","volume":"46","author":"Mohan","year":"2000","journal-title":"Int J Radiat Onc Biol Phys"},{"issue":"(4)","key":"key\n\t\t\t\t20170520235528_CIT0029","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0360-3016(01)01730-8","article-title":"Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life","volume":"51","author":"Kupelian","year":"2001","journal-title":"Int J Radiat Onc Biol Phys"},{"issue":"(4)","key":"key\n\t\t\t\t20170520235528_CIT0030","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0360-3016(00)00734-3","article-title":"Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy","volume":"48","author":"Wilkinson","year":"2000","journal-title":"Int J Radiat Onc Biol Phys"},{"issue":"(2)","key":"key\n\t\t\t\t20170520235528_CIT0031","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"issue":"(5)","key":"key\n\t\t\t\t20170520235528_CIT0032","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520235528_CIT0033","author":"American Society of Hematology"},{"issue":"6","key":"key\n\t\t\t\t20170520235528_CIT0034","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk Res"},{"issue":"(6)","key":"key\n\t\t\t\t20170520235528_CIT0035","first-page":"2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1998","journal-title":"Blood"},{"issue":"(446)","key":"key\n\t\t\t\t20170520235528_CIT0036","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"key\n\t\t\t\t20170520235528_CIT0037","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"1","key":"key\n\t\t\t\t20170520235528_CIT0038","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001\u20132004, using data from the NAACCR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"},{"issue":"(10)","key":"key\n\t\t\t\t20170520235528_CIT0039","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s10552-007-9060-2","article-title":"A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers","volume":"18","author":"De Roos","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"(2)","key":"key\n\t\t\t\t20170520235528_CIT0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1158\/1055-9965.EPI-12-1137","article-title":"Androgen deprivation therapy for treatment of localized prostate cancer and risk of secondary primary malignancies","volume":"22","author":"Wallner","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"(7)","key":"key\n\t\t\t\t20170520235528_CIT0041","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2003.03.114","article-title":"Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience","volume":"21","author":"Smith","year":"2003","journal-title":"J Clin Oncol"},{"issue":"(12)","key":"key\n\t\t\t\t20170520235528_CIT0042","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1200\/JCO.1985.3.12.1640","article-title":"Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience","volume":"3","author":"Fisher","year":"1985","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170520235528_CIT0043","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-103-2-195","article-title":"Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin\u2019s lymphomas","volume":"103","author":"Pedersen-Bjergaard","year":"1985","journal-title":"Ann Intern Med"},{"issue":"6","key":"key\n\t\t\t\t20170520235528_CIT0044","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/1097-0142(19810915)48:6<1299::AID-CNCR2820480608>3.0.CO;2-2","article-title":"Second malignancies in non-Hodgkin\u2019s lymphoma","volume":"48","author":"MacDougall","year":"1981","journal-title":"Cancer"},{"issue":"11","key":"key\n\t\t\t\t20170520235528_CIT0045","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/1097-0142(19821201)50:11<2285::AID-CNCR2820501111>3.0.CO;2-B","article-title":"Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin\u2019s lymphoma: correlation with intensity of treatment","volume":"50","author":"Gomez","year":"1982","journal-title":"Cancer"},{"issue":"12","key":"key\n\t\t\t\t20170520235528_CIT0046","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM198703193161203","article-title":"Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin\u2019s disease","volume":"316","author":"Blayney","year":"1987","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20170520235528_CIT0047","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199001043220102","article-title":"Leukemia following Hodgkin\u2019s disease","volume":"322","author":"Kaldor","year":"1990","journal-title":"New Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20170520235528_CIT0048","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198801143180203","article-title":"Risk of second cancers after treatment for Hodgkin\u2019s disease","volume":"318","author":"Tucker","year":"1988","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20170520235528_CIT0049","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.1986.4.6.830","article-title":"Second acute leukemia and other malignancies following treatment for Hodgkin\u2019s disease","volume":"4","author":"Valagussa","year":"1986","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520235528_CIT0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.1984.tb06057.x","article-title":"Acute leukaemia in patients treated for Hodgkin\u2019s disease","volume":"58","author":"Papa","year":"1984","journal-title":"Br J Haematol"},{"issue":"7","key":"key\n\t\t\t\t20170520235528_CIT0051","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1984.2.7.762","article-title":"Second malignant neoplasms complicating Hodgkin\u2019s disease: the National Cancer Institute experience","volume":"2","author":"Tester","year":"1984","journal-title":"J Clin Oncol"},{"issue":"10","key":"key\n\t\t\t\t20170520235528_CIT0052","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1987.5.10.1624","article-title":"Major complications and causes of death in patients treated for Hodgkin\u2019s disease","volume":"5","author":"Van Rijswijk","year":"1987","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170520235528_CIT0053","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0277-5379(82)90042-6","article-title":"Risk of leukemia in patients treated for Hodgkin\u2019s disease","volume":"18","author":"Brusamolino","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170520235528_CIT0054","first-page":"1035","article-title":"Second malignant neoplasms in patients successfully treated for Hodgkin\u2019s disease: a Cancer and Leukemia Group B study","volume":"66","author":"Glicksman","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"key\n\t\t\t\t20170520235528_CIT0055","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM198210143071601","article-title":"Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin\u2019s disease","volume":"307","author":"Pedersen-Bjergaard","year":"1982","journal-title":"N Engl J Med"},{"issue":"8550","key":"key\n\t\t\t\t20170520235528_CIT0056","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(87)92744-9","article-title":"Risk of therapy related leukaemia and preleukaemia after Hodglan\u2019s disease","volume":"2","author":"Pedersen-Bjeergaard","year":"1987","journal-title":"Lancet"},{"issue":"12","key":"key\n\t\t\t\t20170520235528_CIT0057","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/1097-0142(19831215)52:12<2209::AID-CNCR2820521206>3.0.CO;2-6","article-title":"Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin\u2019s disease","volume":"52","author":"Bartolucci","year":"1983","journal-title":"Cancer"},{"issue":"2","key":"key\n\t\t\t\t20170520235528_CIT0058","first-page":"233","article-title":"Second primary cancers following treatment of Hodgkin\u2019s disease","volume":"72","author":"Boivin","year":"1984","journal-title":"J Nat Cancer Inst"},{"issue":"4","key":"key\n\t\t\t\t20170520235528_CIT0059","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.1985.3.4.501","article-title":"Reduction of fatal complications from combined modality therapy in Hodgkin\u2019s disease","volume":"3","author":"Mauch","year":"1985","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170520235528_CIT0060","first-page":"911","article-title":"Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin\u2019s disease","volume":"71","author":"Henry-Amar","year":"1983","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"key\n\t\t\t\t20170520235528_CIT0061","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JCO.1986.4.3.311","article-title":"Second neoplasms in patients with Hodgkin\u2019s disease following combined modality therapy: the Yale experience","volume":"4","author":"Koletsky","year":"1986","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170520235528_CIT0062","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.1996.14.2.565","article-title":"Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin\u2019s lymphoma","volume":"14","author":"Travis","year":"1996","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520235528_CIT0063","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1200\/JCO.1989.7.1.67","article-title":"Total body irradiation for stage II-IV non-Hodgkin\u2019s lymphoma: ten-year follow-up","volume":"7","author":"Mendenhall","year":"1989","journal-title":"J Clin Oncol"},{"issue":"(7)","key":"key\n\t\t\t\t20170520235528_CIT0064","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2009.02151.x","article-title":"Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions","volume":"39","author":"Valent","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"(4)","key":"key\n\t\t\t\t20170520235528_CIT0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1200\/JCO.2010.31.3080","article-title":"Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors","volume":"29","author":"Iwanaga","year":"2011","journal-title":"J Clin Oncol"},{"issue":"17","key":"key\n\t\t\t\t20170520235528_CIT0066","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2009.25.2395","article-title":"Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries","volume":"28","author":"Goldberg","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/106\/3\/djt462\/17313372\/djt462.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T15:36:35Z","timestamp":1503502595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djt462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,2,27]]},"published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djt462","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,27]]}}}